What is HTFL's current stock price?

HTFL (Heartflow, Inc. Common Stock) is currently trading at $29.49 with a market cap of $2.54B.

What sector is Heartflow, Inc. Common Stock in?

Heartflow, Inc. Common Stock (HTFL) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.

Is HTFL a good stock to buy?

Analysts have a Buy consensus on HTFL with a price target of $37.00. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

HTFL Heartflow, Inc. Common Stock

Healthcare

$29.49+0.99%ClosedMarket Cap: $2.54B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

38.04

P/S

13.29

EV/EBITDA

-29.13

DCF Value

$-2.12

FCF Yield

-3.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

78.1%

Operating Margin

-35.8%

Net Margin

-58.4%

ROE

830.5%

ROA

-32.5%

ROIC

-21.9%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$52.6M	$-27.4M	$—
Q4 null	$49.1M	$-24.4M	$—
FY null	$176.0M	$-116.8M	$—
Q3 null	$46.3M	$-50.9M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$37.00

Target (Median)

$37.00

Target Range

$37.00 - $37.00

2 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell

Canaccord GenuityBuy

2026-05-15

Wells FargoOverweight

2026-05-15

JP MorganOverweight

2026-03-19

Wells FargoOverweight

2026-03-19

Canaccord GenuityBuy

2026-03-19

Trading Activity

Insider Trades

View All

Rogers Campbellofficer: Chief Medical Officer

SellWed May 20

Rogers Campbellofficer: Chief Medical Officer

SellWed May 20

Farquhar John C.M.director, officer: Chief Executive Officer

SellWed May 13

Verghese Vikramofficer: Chief Financial Officer

SellFri May 08

Verghese Vikramofficer: Chief Financial Officer

SellFri May 08

Company Info

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

Exchange

—

Beta

1.99

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.

Peers